First Nebraska Trust Co

Bank

Position in NVS — Novartis AG

CIK 2134841 LINCOLN, NE

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$283,976

+$7,193 QoQ

Shares Held

1,812

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,162

of 1,603 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

First Nebraska Trust Co holds $45,421,134 across 9 Drug Manufacturers - General names. NVS ranks #9 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	67,346	$17,103,863
2	MRK	Merck & Co., Inc.	104,140	$13,381,990
3	LLY	ELI LILLY & Co	6,923	$8,303,654
4	PFE	Pfizer Inc	106,986	$2,576,222
5	ABBV	AbbVie Inc.	7,172	$1,804,762
6	AMGN	Amgen Inc	2,369	$857,862
7	BMY	Bristol Myers Squibb Co	10,907	$628,461
8	GILD	Gilead Sciences, Inc.	3,802	$480,344

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$283,976	1,812	0.0%	Shares	Sole	2026-08-12
2026-03-31	$276,783	1,812	-4.0%	Shares	Sole	2026-06-01
2025-12-31	$260,160	1,887	0.0%	Shares	Sole	2026-06-02
2025-09-30	$241,988	1,887	0.0%	Shares	Sole	2026-06-09
2025-06-30	$228,345	1,887	-8.6%	Shares	Sole	2026-06-10
2025-03-31	$230,094	2,064	0.0%	Shares	Sole	2026-06-10
2024-12-31	$200,847	2,064	0.0%	Shares	Sole	2026-06-12
2024-09-30	$237,401	2,064	0.0%	Shares	Sole	2026-06-12
2024-06-30	$219,733	2,064	-0.5%	Shares	Sole	2026-06-15
2024-03-31	$200,618	2,074	0.0%	Shares	Sole	2026-06-16
2023-12-31	$209,411	2,074	0.0%	Shares	Sole	2026-06-16
2023-09-30	$211,257	2,074	0.0%	Shares	Sole	2026-06-16
2023-06-30	$209,287	2,074	—	Shares	Sole	2026-06-17
No filing history on record for this holder in this stock.